{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:02:40Z","timestamp":1793311360150,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["P2022R43RA"],"award-info":[{"award-number":["P2022R43RA"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chemotherapy-induced peripheral neurotoxicity (CIPN) is one common side effect associated with antineoplastic agents. Despite its relevance, the underlying mechanisms remain poorly understood. In this study, we explored cytokines and macrophages that contribute to two chronic models of CIPN comparing paclitaxel (PTX)- and oxaliplatin (OHP)-induced CIPN in rats. To detect chemotherapy-induced sensory or neuronal abnormalities behavioral tests, pathological and morphometric analysis were used. To investigate systemic inflammation, a panel including IL-6, IL-1\u03b2, IL-2, IL-10, GRO\/KC(CXCL1), TNF\u03b1, IFN\u03b3 were tested in serum. Besides, we analyzed dorsal root ganglia (DRG), caudal nerves and spinal cord mRNA expression of a panel of pro-inflammatory markers IL-6, CCL2 and NLRP3, as well as caudal macrophage infiltration. We evidenced a remarkable difference in caudal macrophage infiltration in PTX- vs. OHP-treated rats, which was associated with serum CXCL1 and to a different IL-6 expression pattern in serum, DRG, spinal cord and caudal nerve. Moreover, CCL2, NLRP3 upregulation was also increased in the caudal nerves in PTX-treated animals. On the contrary, OHP induced IL-6 and CCL2 expression in DRG. Since our results suggest that CXCL1 or IL-6 could be considered as critical lynchpins between inflammation pain and CIPN, targeting early inflammatory events could be a promising therapeutic approach.<\/jats:p>","DOI":"10.1038\/s41598-025-34830-6","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:27:53Z","timestamp":1768292873000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Interleukin-6 as a keystone cytokine in experimental rat models of chemotherapy-induced peripheral neurotoxicity"],"prefix":"10.1038","volume":"16","author":[{"given":"Olga","family":"Tarasiuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3469-1829","authenticated-orcid":false,"given":"Alessia","family":"Chiorazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Argentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Ballarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4946-647X","authenticated-orcid":false,"given":"Annalisa","family":"Canta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0963-7107","authenticated-orcid":false,"given":"Valentina Alda","family":"Carozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6438-286X","authenticated-orcid":false,"given":"Eleonora","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6106-6183","authenticated-orcid":false,"given":"Paola","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Fabbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1981-1204","authenticated-orcid":false,"given":"Federico","family":"Iseppon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Foti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4281-4577","authenticated-orcid":false,"given":"Cristina","family":"Meregalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"34830_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14246088","author":"P Alberti","year":"2022","unstructured":"Alberti, P. et al. Neurological complications of conventional and novel anticancer treatments. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers14246088 (2022).","journal-title":"Cancers (Basel)"},{"key":"34830_CR2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fnmol.2017.00174","volume":"10","author":"H Starobova","year":"2017","unstructured":"Starobova, H. & Vetter, I. Pathophysiology of chemotherapy-induced peripheral neuropathy. Front. Mol. Neurosci. 10, 174. https:\/\/doi.org\/10.3389\/fnmol.2017.00174 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"34830_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3389\/fnins.2017.00481","volume":"11","author":"Y Fukuda","year":"2017","unstructured":"Fukuda, Y., Li, Y. & Segal, R. A. A mechanistic understanding of axon degeneration in chemotherapy-induced peripheral neuropathy. Front. Neurosci. 11, 481. https:\/\/doi.org\/10.3389\/fnins.2017.00481 (2017).","journal-title":"Front. Neurosci."},{"key":"34830_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2217\/pmt.15.19","volume":"5","author":"JA Boyette-Davis","year":"2015","unstructured":"Boyette-Davis, J. A., Walters, E. T. & Dougherty, P. M. Mechanisms involved in the development of chemotherapy-induced neuropathy. Pain Manag. 5, 285\u2013296. https:\/\/doi.org\/10.2217\/pmt.15.19 (2015).","journal-title":"Pain Manag."},{"key":"34830_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/WCO.0000000000000234","volume":"28","author":"G Cavaletti","year":"2015","unstructured":"Cavaletti, G. & Marmiroli, P. Chemotherapy-induced peripheral neurotoxicity. Curr. Opin. Neurol. 28, 500\u2013507. https:\/\/doi.org\/10.1097\/WCO.0000000000000234 (2015).","journal-title":"Curr. Opin. Neurol."},{"key":"34830_CR6","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/cncr.27732","volume":"119","author":"AA Argyriou","year":"2013","unstructured":"Argyriou, A. A. et al. Clinical pattern and associations of oxaliplatin acute neurotoxicity: A prospective study in 170 patients with colorectal cancer. Cancer 119, 438\u2013444. https:\/\/doi.org\/10.1002\/cncr.27732 (2013).","journal-title":"Cancer"},{"key":"34830_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.135941","volume":"755","author":"ML Uhelski","year":"2021","unstructured":"Uhelski, M. L., Li, Y., Fonseca, M. M., Romero-Snadoval, E. A. & Dougherty, P. M. Role of innate immunity in chemotherapy-induced peripheral neuropathy. Neurosci. Lett. 755, 135941. https:\/\/doi.org\/10.1016\/j.neulet.2021.135941 (2021).","journal-title":"Neurosci. Lett."},{"key":"34830_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.626687","volume":"11","author":"G Fumagalli","year":"2020","unstructured":"Fumagalli, G., Monza, L., Cavaletti, G., Rigolio, R. & Meregalli, C. Neuroinflammatory process involved in different preclinical models of chemotherapy-induced peripheral neuropathy. Front. Immunol. 11, 626687. https:\/\/doi.org\/10.3389\/fimmu.2020.626687 (2020).","journal-title":"Front. Immunol."},{"key":"34830_CR9","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nrneurol.2014.211","volume":"10","author":"M Sisignano","year":"2014","unstructured":"Sisignano, M., Baron, R., Scholich, K. & Geisslinger, G. Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain. Nat. Rev. Neurol. 10, 694\u2013707. https:\/\/doi.org\/10.1038\/nrneurol.2014.211 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"34830_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ejca.2016.12.006","volume":"73","author":"JG Lees","year":"2017","unstructured":"Lees, J. G. et al. Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy. Eur. J. Cancer 73, 22\u201329. https:\/\/doi.org\/10.1016\/j.ejca.2016.12.006 (2017).","journal-title":"Eur. J. Cancer"},{"key":"34830_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/life14080991","author":"M Mattar","year":"2024","unstructured":"Mattar, M. et al. Chemotherapy-induced peripheral neuropathy: A recent update on pathophysiology and treatment. Life (Basel) https:\/\/doi.org\/10.3390\/life14080991 (2024).","journal-title":"Life (Basel)"},{"key":"34830_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217433","volume":"611","author":"Z Tao","year":"2024","unstructured":"Tao, Z., Chen, Z., Zeng, X., Cui, J. & Quan, M. An emerging aspect of cancer neuroscience: A literature review on chemotherapy-induced peripheral neuropathy. Cancer Lett. 611, 217433. https:\/\/doi.org\/10.1016\/j.canlet.2024.217433 (2024).","journal-title":"Cancer Lett."},{"key":"34830_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12974-022-02454-6","volume":"19","author":"Z Msheik","year":"2022","unstructured":"Msheik, Z., El Massry, M., Rovini, A., Billet, F. & Desmouli\u00e8re, A. The macrophage: A key player in the pathophysiology of peripheral neuropathies. J. Neuroinflammation 19, 97. https:\/\/doi.org\/10.1186\/s12974-022-02454-6 (2022).","journal-title":"J. Neuroinflammation"},{"key":"34830_CR14","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1097\/j.pain.0000000000003268","volume":"165","author":"G Cavaletti","year":"2024","unstructured":"Cavaletti, G. et al. Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: The importance of model selection. Pain 165, 2482\u20132493. https:\/\/doi.org\/10.1097\/j.pain.0000000000003268 (2024).","journal-title":"Pain"},{"key":"34830_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11020139","author":"L Monza","year":"2021","unstructured":"Monza, L., Fumagalli, G., Chiorazzi, A. & Alberti, P. Addressing the need of a translational approach in peripheral neuropathy research: Morphology meets function. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci11020139 (2021).","journal-title":"Brain Sci."},{"key":"34830_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/jns.12609","volume":"29","author":"R Bonomo","year":"2024","unstructured":"Bonomo, R. et al. Effect of age on metabolomic changes in a model of paclitaxel-induced peripheral neurotoxicity. J., Peripher. Nerv. Syst. 29, 58\u201371. https:\/\/doi.org\/10.1111\/jns.12609 (2024).","journal-title":"J., Peripher. Nerv. Syst."},{"key":"34830_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/jns.12607","volume":"29","author":"A Chiorazzi","year":"2024","unstructured":"Chiorazzi, A. et al. Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: The role of nerve excitability testing. J. Peripher. Nerv. Syst. 29, 47\u201357. https:\/\/doi.org\/10.1111\/jns.12607 (2024).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"34830_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031058","author":"C Meregalli","year":"2021","unstructured":"Meregalli, C. et al. Human intravenous immunoglobulin alleviates neuropathic symptoms in a rat model of paclitaxel-induced peripheral neurotoxicity. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22031058 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"34830_CR19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ejpain.2009.07.001","volume":"14","author":"C Meregalli","year":"2010","unstructured":"Meregalli, C. et al. Bortezomib-induced painful neuropathy in rats: A behavioral, neurophysiological and pathological study in rats. Eur. J. Pain 14, 343\u2013350. https:\/\/doi.org\/10.1016\/j.ejpain.2009.07.001 (2010).","journal-title":"Eur. J. Pain"},{"key":"34830_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186250","volume":"12","author":"P Marmiroli","year":"2017","unstructured":"Marmiroli, P. et al. Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights. PLoS ONE 12, e0186250. https:\/\/doi.org\/10.1371\/journal.pone.0186250 (2017).","journal-title":"PLoS ONE"},{"key":"34830_CR21","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ejca.2008.10.038","volume":"45","author":"V Carozzi","year":"2009","unstructured":"Carozzi, V. et al. Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity. Eur. J. Cancer 45, 656\u2013665. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.038 (2009).","journal-title":"Eur. J. Cancer"},{"key":"34830_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/toxics11020093","author":"E Pozzi","year":"2023","unstructured":"Pozzi, E. et al. Paclitaxel, but not cisplatin, affects satellite glial cells in dorsal root ganglia of rats with chemotherapy-induced peripheral neurotoxicity. Toxics https:\/\/doi.org\/10.3390\/toxics11020093 (2023).","journal-title":"Toxics"},{"key":"34830_CR23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/BF00227662","volume":"84","author":"G Cavaletti","year":"1992","unstructured":"Cavaletti, G. et al. Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats. Acta Neuropathol. 84, 364\u2013371. https:\/\/doi.org\/10.1007\/BF00227662 (1992).","journal-title":"Acta Neuropathol."},{"key":"34830_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jim.2017.10.002","volume":"452","author":"L Cohen","year":"2018","unstructured":"Cohen, L., Xie, L., Xylas, M. E. & Walt, D. R. Single molecule arrays for ultra-sensitive detection of rat cytokines in serum. J. Immunol. Methods 452, 20\u201325. https:\/\/doi.org\/10.1016\/j.jim.2017.10.002 (2018).","journal-title":"J. Immunol. Methods"},{"key":"34830_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1744-8069-7-29","volume":"7","author":"CL Renn","year":"2011","unstructured":"Renn, C. L. et al. Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice. Mol. Pain 7, 29. https:\/\/doi.org\/10.1186\/1744-8069-7-29 (2011).","journal-title":"Mol. Pain"},{"key":"34830_CR26","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1016\/s0959-8049(01)00300-8","volume":"37","author":"G Cavaletti","year":"2001","unstructured":"Cavaletti, G. et al. Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. Eur. J. Cancer 37, 2457\u20132463. https:\/\/doi.org\/10.1016\/s0959-8049(01)00300-8 (2001).","journal-title":"Eur. J. Cancer"},{"key":"34830_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20122904","author":"L Brandolini","year":"2019","unstructured":"Brandolini, L., d\u2019Angelo, M., Antonosante, A., Allegretti, M. & Cimini, A. Chemokine signaling in chemotherapy-induced neuropathic pain. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20122904 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"34830_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ejps.2009.08.009","volume":"38","author":"A Javeed","year":"2009","unstructured":"Javeed, A. et al. Paclitaxel and immune system. Eur. J. Pharm. Sci. 38, 283\u2013290. https:\/\/doi.org\/10.1016\/j.ejps.2009.08.009 (2009).","journal-title":"Eur. J. Pharm. Sci."},{"key":"34830_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nri2216","volume":"8","author":"L Zitvogel","year":"2008","unstructured":"Zitvogel, L., Apetoh, L., Ghiringhelli, F. & Kroemer, G. Immunological aspects of cancer chemotherapy. Nat. Rev. Immunol. 8, 59\u201373. https:\/\/doi.org\/10.1038\/nri2216 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"34830_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.expneurol.2006.07.022","volume":"203","author":"CM Peters","year":"2007","unstructured":"Peters, C. M. et al. Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells. Exp. Neurol. 203, 42\u201354. https:\/\/doi.org\/10.1016\/j.expneurol.2006.07.022 (2007).","journal-title":"Exp. Neurol."},{"key":"34830_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.brainres.2007.06.066","volume":"1168","author":"CM Peters","year":"2007","unstructured":"Peters, C. M., Jimenez-Andrade, J. M., Kuskowski, M. A., Ghilardi, J. R. & Mantyh, P. W. An evolving cellular pathology occurs in dorsal root ganglia, peripheral nerve and spinal cord following intravenous administration of paclitaxel in the rat. Brain Res. 1168, 46\u201359. https:\/\/doi.org\/10.1016\/j.brainres.2007.06.066 (2007).","journal-title":"Brain Res."},{"key":"34830_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cyto.2012.03.027","volume":"59","author":"XM Wang","year":"2012","unstructured":"Wang, X. M., Lehky, T. J., Brell, J. M. & Dorsey, S. G. Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy. Cytokine 59, 3\u20139. https:\/\/doi.org\/10.1016\/j.cyto.2012.03.027 (2012).","journal-title":"Cytokine"},{"key":"34830_CR33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/jns.12660","volume":"29","author":"AG Zippo","year":"2024","unstructured":"Zippo, A. G. et al. Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy. J. Peripher. Nerv. Syst. 29, 537\u2013554. https:\/\/doi.org\/10.1111\/jns.12660 (2024).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"34830_CR34","doi-asserted-by":"publisher","first-page":"1264668","DOI":"10.3389\/fvets.2023.1264668","volume":"10","author":"C Bacalhau","year":"2023","unstructured":"Bacalhau, C., Costa-Pereira, J. T. & Tavares, I. Preclinical research in paclitaxel-induced neuropathic pain: A systematic review. Front. Vet. Sci. 10, 1264668. https:\/\/doi.org\/10.3389\/fvets.2023.1264668 (2023).","journal-title":"Front. Vet. Sci."},{"key":"34830_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050239","volume":"5","author":"CW Lees","year":"2008","unstructured":"Lees, C. W. et al. Analysis of germline GLI1 variation implicates hedgehog signalling in the regulation of intestinal inflammatory pathways. PLoS Med. 5, e239. https:\/\/doi.org\/10.1371\/journal.pmed.0050239 (2008).","journal-title":"PLoS Med."},{"key":"34830_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/jns.12432","volume":"26","author":"G Wei","year":"2021","unstructured":"Wei, G. et al. Platinum accumulation in oxaliplatin-induced peripheral neuropathy. J. Peripher. Nerv. Syst. 26, 35\u201342. https:\/\/doi.org\/10.1111\/jns.12432 (2021).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"34830_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170814","volume":"12","author":"PG Makker","year":"2017","unstructured":"Makker, P. G. et al. Characterisation of immune and neuroinflammatory changes associated with chemotherapy-induced peripheral neuropathy. PLoS ONE 12, e0170814. https:\/\/doi.org\/10.1371\/journal.pone.0170814 (2017).","journal-title":"PLoS ONE"},{"key":"34830_CR38","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.jpain.2013.08.002","volume":"14","author":"L Di Cesare Mannelli","year":"2013","unstructured":"Di Cesare Mannelli, L. et al. Morphologic features and glial activation in rat oxaliplatin-dependent neuropathic pain. J. Pain 14, 1585\u20131600. https:\/\/doi.org\/10.1016\/j.jpain.2013.08.002 (2013).","journal-title":"J. Pain"},{"key":"34830_CR39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12974-019-1581-6","volume":"16","author":"M Tsubota","year":"2019","unstructured":"Tsubota, M. et al. Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin\/thrombomodulin system in rodents: Negative impact of anticoagulants. J. Neuroinflammation 16, 199. https:\/\/doi.org\/10.1186\/s12974-019-1581-6 (2019).","journal-title":"J. Neuroinflammation"},{"key":"34830_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/toxins8010027","author":"D Li","year":"2016","unstructured":"Li, D. et al. Preventive effects of bee venom derived phospholipase A\u2082 on oxaliplatin-induced neuropathic pain in mice. Toxins (Basel) https:\/\/doi.org\/10.3390\/toxins8010027 (2016).","journal-title":"Toxins (Basel)"},{"key":"34830_CR41","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1002\/ijc.32652","volume":"146","author":"H Gu","year":"2020","unstructured":"Gu, H. et al. High mobility group box-1-toll-like receptor 4-phosphatidylinositol 3-kinase\/protein kinase B-mediated generation of matrix metalloproteinase-9 in the dorsal root ganglion promotes chemotherapy-induced peripheral neuropathy. Int. J. Cancer 146, 2810\u20132821. https:\/\/doi.org\/10.1002\/ijc.32652 (2020).","journal-title":"Int. J. Cancer"},{"key":"34830_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.expneurol.2014.06.016","volume":"261","author":"L Di Cesare Mannelli","year":"2014","unstructured":"Di Cesare Mannelli, L. et al. Glial role in oxaliplatin-induced neuropathic pain. Exp. Neurol. 261, 22\u201333. https:\/\/doi.org\/10.1016\/j.expneurol.2014.06.016 (2014).","journal-title":"Exp. Neurol."},{"key":"34830_CR43","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/j.1532-2149.2012.00219.x","volume":"17","author":"RA Warwick","year":"2013","unstructured":"Warwick, R. A. & Hanani, M. The contribution of satellite glial cells to chemotherapy-induced neuropathic pain. Eur. J. Pain 17, 571\u2013580. https:\/\/doi.org\/10.1002\/j.1532-2149.2012.00219.x (2013).","journal-title":"Eur. J. Pain"},{"key":"34830_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11111482","author":"P Chauhan","year":"2021","unstructured":"Chauhan, P., Sheng, W. S., Hu, S., Prasad, S. & Lokensgard, J. R. Differential cytokine-induced responses of polarized microglia. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci11111482 (2021).","journal-title":"Brain Sci."},{"key":"34830_CR45","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1097\/j.pain.0000000000000158","volume":"156","author":"D Fang","year":"2015","unstructured":"Fang, D. et al. Interleukin-6-mediated functional upregulation of TRPV1 receptors in dorsal root ganglion neurons through the activation of JAK\/PI3K signaling pathway: Roles in the development of bone cancer pain in a rat model. Pain 156, 1124\u20131144. https:\/\/doi.org\/10.1097\/j.pain.0000000000000158 (2015).","journal-title":"Pain"},{"key":"34830_CR46","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.pain.2013.03.026","volume":"154","author":"J Guptarak","year":"2013","unstructured":"Guptarak, J. et al. Inhibition of IL-6 signaling: A novel therapeutic approach to treating spinal cord injury pain. Pain 154, 1115\u20131128. https:\/\/doi.org\/10.1016\/j.pain.2013.03.026 (2013).","journal-title":"Pain"},{"key":"34830_CR47","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neulet.2008.09.009","volume":"445","author":"N Kiguchi","year":"2008","unstructured":"Kiguchi, N., Maeda, T., Kobayashi, Y. & Kishioka, S. Up-regulation of tumor necrosis factor-alpha in spinal cord contributes to vincristine-induced mechanical allodynia in mice. Neurosci. Lett. 445, 140\u2013143. https:\/\/doi.org\/10.1016\/j.neulet.2008.09.009 (2008).","journal-title":"Neurosci. Lett."},{"issue":"682","key":"34830_CR48","doi-asserted-by":"publisher","first-page":"e681","DOI":"10.1016\/j.ejpain.2009.10.017","volume":"14","author":"KM Lee","year":"2010","unstructured":"Lee, K. M., Jeon, S. M. & Cho, H. J. Interleukin-6 induces microglial CX3CR1 expression in the spinal cord after peripheral nerve injury through the activation of p38 MAPK. Eur. J. Pain 14(682), e681\u2013e612. https:\/\/doi.org\/10.1016\/j.ejpain.2009.10.017 (2010).","journal-title":"Eur. J. Pain"},{"key":"34830_CR49","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/547834","volume":"2015","author":"F Magrinelli","year":"2015","unstructured":"Magrinelli, F. et al. The association between serum cytokines and damage to large and small nerve fibers in diabetic peripheral neuropathy. J. Diabetes Res. 2015, 547834. https:\/\/doi.org\/10.1155\/2015\/547834 (2015).","journal-title":"J. Diabetes Res."},{"key":"34830_CR50","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/281531","volume":"2010","author":"A Starkweather","year":"2010","unstructured":"Starkweather, A. Increased interleukin-6 activity associated with painful chemotherapy-induced peripheral neuropathy in women after breast cancer treatment. Nurs. Res. Pract. 2010, 281531. https:\/\/doi.org\/10.1155\/2010\/281531 (2010).","journal-title":"Nurs. Res. Pract."},{"key":"34830_CR51","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1744-8069-7-73","volume":"7","author":"S Quarta","year":"2011","unstructured":"Quarta, S. et al. Genetic evidence for an essential role of neuronally expressed IL-6 signal transducer gp130 in the induction and maintenance of experimentally induced mechanical hypersensitivity in vivo and in vitro. Mol. Pain 7, 73. https:\/\/doi.org\/10.1186\/1744-8069-7-73 (2011).","journal-title":"Mol. Pain"},{"key":"34830_CR52","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21952","volume":"14","author":"D Chanda","year":"2022","unstructured":"Chanda, D., Ray, S., Chakraborti, D., Sen, S. & Mitra, A. Interleukin-6 levels in patients with diabetic polyneuropathy. Cureus 14, e21952. https:\/\/doi.org\/10.7759\/cureus.21952 (2022).","journal-title":"Cureus"},{"key":"34830_CR53","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41419-020-2239-0","volume":"11","author":"P Huehnchen","year":"2020","unstructured":"Huehnchen, P., Muenzfeld, H., Boehmerle, W. & Endres, M. Blockade of IL-6 signaling prevents paclitaxel-induced neuropathy in C57Bl\/6 mice. Cell Death Dis. 11, 45. https:\/\/doi.org\/10.1038\/s41419-020-2239-0 (2020).","journal-title":"Cell Death Dis."},{"key":"34830_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109219","volume":"112","author":"K Hisaoka-Nakashima","year":"2022","unstructured":"Hisaoka-Nakashima, K. et al. Anti-interleukin-6 receptor antibody improves allodynia and cognitive impairment in mice with neuropathic pain following partial sciatic nerve ligation. Int. Immunopharmacol. 112, 109219. https:\/\/doi.org\/10.1016\/j.intimp.2022.109219 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"34830_CR55","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201452","author":"H Starobova","year":"2021","unstructured":"Starobova, H. et al. Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1\u03b2 release. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20201452 (2021).","journal-title":"J. Exp. Med."},{"key":"34830_CR56","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3892\/etm.2013.1296","volume":"6","author":"T Murakami","year":"2013","unstructured":"Murakami, T. et al. Anti-interleukin-6 receptor antibody reduces neuropathic pain following spinal cord injury in mice. Exp. Ther. Med. 6, 1194\u20131198. https:\/\/doi.org\/10.3892\/etm.2013.1296 (2013).","journal-title":"Exp. Ther. Med."},{"key":"34830_CR57","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejphar.2008.07.008","volume":"592","author":"N Kiguchi","year":"2008","unstructured":"Kiguchi, N. et al. The critical role of invading peripheral macrophage-derived interleukin-6 in vincristine-induced mechanical allodynia in mice. Eur. J. Pharmacol. 592, 87\u201392. https:\/\/doi.org\/10.1016\/j.ejphar.2008.07.008 (2008).","journal-title":"Eur. J. Pharmacol."},{"key":"34830_CR58","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jneuroim.2010.08.013","volume":"229","author":"PJ Austin","year":"2010","unstructured":"Austin, P. J. & Moalem-Taylor, G. The neuro-immune balance in neuropathic pain: Involvement of inflammatory immune cells, immune-like glial cells and cytokines. J. Neuroimmunol. 229, 26\u201350. https:\/\/doi.org\/10.1016\/j.jneuroim.2010.08.013 (2010).","journal-title":"J. Neuroimmunol."},{"key":"34830_CR59","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.coph.2011.10.007","volume":"12","author":"N Kiguchi","year":"2012","unstructured":"Kiguchi, N., Kobayashi, Y. & Kishioka, S. Chemokines and cytokines in neuroinflammation leading to neuropathic pain. Curr Opin Pharmacol 12, 55\u201361. https:\/\/doi.org\/10.1016\/j.coph.2011.10.007 (2012).","journal-title":"Curr Opin Pharmacol"},{"key":"34830_CR60","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.pharmthera.2006.04.001","volume":"112","author":"WA Verri","year":"2006","unstructured":"Verri, W. A. et al. Hypernociceptive role of cytokines and chemokines: Targets for analgesic drug development?. Pharmacol. Ther. 112, 116\u2013138. https:\/\/doi.org\/10.1016\/j.pharmthera.2006.04.001 (2006).","journal-title":"Pharmacol. Ther."},{"key":"34830_CR61","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/s0165-5728(99)00266-0","volume":"104","author":"KB Bacon","year":"2000","unstructured":"Bacon, K. B. & Harrison, J. K. Chemokines and their receptors in neurobiology: Perspectives in physiology and homeostasis. J. Neuroimmunol. 104, 92\u201397. https:\/\/doi.org\/10.1016\/s0165-5728(99)00266-0 (2000).","journal-title":"J. Neuroimmunol."},{"key":"34830_CR62","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.4049\/jimmunol.158.6.2882","volume":"158","author":"R Horuk","year":"1997","unstructured":"Horuk, R. et al. Expression of chemokine receptors by subsets of neurons in the central nervous system. J. Immunol. 158, 2882\u20132890 (1997).","journal-title":"J. Immunol."},{"key":"34830_CR63","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/s0165-3806(01)00128-6","volume":"128","author":"D Nguyen","year":"2001","unstructured":"Nguyen, D. & Stangel, M. Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglial cells. Brain Res. Dev. Brain Res 128, 77\u201381. https:\/\/doi.org\/10.1016\/s0165-3806(01)00128-6 (2001).","journal-title":"Brain Res. Dev. Brain Res"},{"key":"34830_CR64","doi-asserted-by":"publisher","first-page":"23188","DOI":"10.18632\/oncotarget.15533","volume":"8","author":"L Brandolini","year":"2017","unstructured":"Brandolini, L. et al. CXCR1\/2 pathways in paclitaxel-induced neuropathic pain. Oncotarget 8, 23188\u201323201. https:\/\/doi.org\/10.18632\/oncotarget.15533 (2017).","journal-title":"Oncotarget"},{"key":"34830_CR65","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.pain.2013.07.002","volume":"154","author":"ZJ Zhang","year":"2013","unstructured":"Zhang, Z. J., Cao, D. L., Zhang, X., Ji, R. R. & Gao, Y. J. Chemokine contribution to neuropathic pain: Respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons. Pain 154, 2185\u20132197. https:\/\/doi.org\/10.1016\/j.pain.2013.07.002 (2013).","journal-title":"Pain"},{"key":"34830_CR66","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.neuropharm.2019.04.014","volume":"151","author":"MN Manjavachi","year":"2019","unstructured":"Manjavachi, M. N. et al. Spinal blockage of CXCL1 and its receptor CXCR2 inhibits paclitaxel-induced peripheral neuropathy in mice. Neuropharmacology 151, 136\u2013143. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.04.014 (2019).","journal-title":"Neuropharmacology"},{"key":"34830_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173039","volume":"875","author":"TR Moraes","year":"2020","unstructured":"Moraes, T. R., Elisei, L. S., Malta, I. H. & Galdino, G. Participation of CXCL1 in the glial cells during neuropathic pain. Eur. J. Pharmacol. 875, 173039. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173039 (2020).","journal-title":"Eur. J. Pharmacol."},{"key":"34830_CR68","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1744-8069-4-38","volume":"4","author":"JG Wang","year":"2008","unstructured":"Wang, J. G. et al. The chemokine CXCL1\/growth related oncogene increases sodium currents and neuronal excitability in small diameter sensory neurons. Mol. Pain 4, 38. https:\/\/doi.org\/10.1186\/1744-8069-4-38 (2008).","journal-title":"Mol. Pain"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34830-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34830-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34830-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:40:11Z","timestamp":1770288011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34830-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34830"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34830-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5127"}}